Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hepatic Hemodynamic Changes and Simulation in Living-Related Liver Transplantation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Information provided by:
National Taiwan University Hospital Identifier:
First received: October 5, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
This 1-year project is intended to study the hemodynamic changes of poratal and hepatic artery during living related liver transplantation. We hypothesize that after right hepatectomy for living related liver transplatation, portal vein overflow will change the remnant liver contour and result in liver hyperplasia.

Right Hepatectomy

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Hepatic Hemodynamic Changes and Simulation Before /After Living-Related Liver Transplantation in Donors/Recipients

Resource links provided by NLM:

Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 10
Study Start Date: September 2005
Detailed Description:
We use CT as tools to reconstruct 3D images of portal vein and hepatic artery before and one month after operation. The images are transferred to CAD and computer simulation is performed.

Ages Eligible for Study:   21 Years to 65 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria: - Informed adult-to adult living donor underwent right lobectomy

Exclusion Criteria:

  • no written informed contents
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00234624

Contact: Cheng-Maw Ho, MD +886-2-23123456 ext 9801914
Contact: Po-Huang Lee, PhD

NTUH Recruiting
Taipei, Taiwan, 100
Contact: Cheng-Maw Ho, MD    +886-2-23123456 ext 9801914   
Contact: Po-Huang Lee, PhD    +886-2-23123456 ext 5104   
Sub-Investigator: Cheng-Maw Ho, MD         
Principal Investigator: Po-Huang Lee, PhD         
Sponsors and Collaborators
National Taiwan University Hospital
Principal Investigator: Po-Huang Lee, PhD NTUH
  More Information Identifier: NCT00234624     History of Changes
Other Study ID Numbers: 9461700821 
Study First Received: October 5, 2005
Last Updated: October 5, 2005
Health Authority: Taiwan: Department of Health processed this record on October 26, 2016